Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
202M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
15.2M
-
Shares change
-
-1.51M
-
Total reported value, excl. options
-
$26.1M
-
Value change
-
-$2.79M
-
Put/Call ratio
-
0.31
-
Number of buys
-
35
-
Number of sells
-
-43
-
Price
-
$1.72
Significant Holders of ATAI Life Sciences N.V. - Common Shares (ATAI) as of Q2 2023
118 filings reported holding ATAI - ATAI Life Sciences N.V. - Common Shares as of Q2 2023.
ATAI Life Sciences N.V. - Common Shares (ATAI) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.2M shares
of 202M outstanding shares and own 7.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.46M shares), MORGAN STANLEY (2.11M shares), MILLENNIUM MANAGEMENT LLC (1.11M shares), Cerity Partners LLC (925K shares), STATE STREET CORP (878K shares), Brown University (719K shares), BANK OF AMERICA CORP /DE/ (562K shares), Mirae Asset Global Investments Co., Ltd. (544K shares), VANGUARD GROUP INC (520K shares), and CREDIT SUISSE AG/ (421K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.